Technical update on HIV-1/2 differentiation assays

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

i

Technical update on HIV-1/2 differentiation assays

8/12/2016
By Centers for Disease Control and Prevention (U.S.) ...
Source: To be used in conjunction with: Laboratory testing for the diagnosis of HIV infection : updated recommendations.

English

Details You May Also Like

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.) ; Association of Public Health Laboratories. ; National Center for HIV/AIDS, Viral Hepatitis, and TB Prevention (U.S.). Division of HIV/AIDS Prevention.

Centers for Disease Control and Prevention (U.S.) ; Association of Public Health Laboratories. ; National Center for HIV/AIDS, Viral Hepatitis, and TB Prevention (U.S.). Division of HIV/AIDS Prevention. Less -
Description:

In response to changes in the commercial availability of HIV-1/HIV-2 antibody differentiation assays approved by the U.S. Food and Drug Administration (FDA) for diagnostic use, the Centers for Disease Control and Prevention (CDC) and the Association of Public Health Laboratories (APHL) are writing to share information on the only available differentiation assay as well as interim solutions for HIV testing.

The CDC and APHL continue to recommend that laboratories use a laboratory-based HIV antigen/antibody HIV screening immunoassay, followed, when reactive, by an HIV-1/HIV-2 antibody differentiation immunoassay. When the differentiation assay returns a negative or indeterminate result, perform an HIV-1 nucleic acid test (NAT).1 In addition to being accurate, HIV testing should be expedited to reduce the time to antiretroviral treatment because infected persons have better health outcomes when they are treated earlier and treatment of infected persons reduces transmission of HIV to others.

cdc-hiv-technical-update-differentiation-test.pdf
Subjects:

[+]

AIDS Serodiagnosis/methods Algorithms Enzyme-Linked Immunosorbent Assay HIV-1 HIV-2 HIV Antigens/analysis HIV Infections/diagnosis HIV Seropositivity/diagnosis Luminescent Measurements Nucleic Acid Amplification Techniques
Source:

To be used in conjunction with: Laboratory testing for the diagnosis of HIV infection : updated recommendations.
Place as Subject:

United States
Pages in Document:

3 numbered pages
Collection(s):

Guidelines and Recommendations
Main Document Checksum:

[+]

urn:sha256:a714a312841b8f8119eec2d2b9baa35a571e1e83c932c0e6d693364242972c77
Download URL:

https://stacks.cdc.gov/view/cdc/40790/cdc_40790_DS1.pdf
File Type:

[PDF-97.69 KB]